NKGen Biotech

NKGen Biotech EBIT per Share

The EBIT per Share of NKGen Biotech (NKGN) as of Oct 9, 2026 is -0.94 USD. In the previous year, EBIT per Share was -3.76 USD — a change of -75.09% (higher).

EBIT per Share

-0.94USD

YoY

-75.09%

Last updated:

EBIT per Share of NKGen Biotech is 2025 -0.94 USD. EBIT per Share of NKGen Biotech was 2024 -3.76 USD. It decreases by -75.09% higher compared to the previous year.

The NKGen Biotech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2020
0.00 USD
Jan 1, 2021
-1.02 USD
Jan 1, 2022
-1.14 USD
Jan 1, 2023
-3.76 USD
Jan 1, 2025
-0.94 USD
The NKGen Biotech EBIT per Share history
YEAREBIT per ShareYoY
-0.94USD-75.09%
-3.76USD+229.61%
-1.14USD+11.37%
-1.02USD—
0.00USD—
Access this data via the Eulerpool API
Get Free API Key

NKGen Biotech Stock analysis

What does NKGen Biotech do? NKGen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NKGen Biotech stock

EBIT per Share of NKGen Biotech is -0.94 USD in 2025.

EBIT per Share of NKGen Biotech changed from -3.76 USD to -0.94 USD, representing a -75.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share NKGen Biotech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NKGen Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NKGen Biotech